Gabapentin Market Analysis

  • Report ID: 5130
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Gabapentin Market Analysis

Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)

The hospital pharmacy segment is anticipated to account for 45% share of the global gabapentin market during the projected period. The hospital pharmacies also have exposure to patients' medical records which leads to high accuracy in medication provision. Besides, the growing demand for advanced healthcare infrastructure, especially in developing countries along with high investment in new technologies and the healthcare sector is expected to influence the segment growth in the upcoming times. Given the risk of misuse, most medicines are provided by hospitals or the healthcare industry. According to a US national survey, 6.6% of persons reported misusing gabapentin at some point in their lives, with therapeutic and non-therapeutic uses split fairly evenly.

Dosage Form (Tablet, Capsule, Oral Solution) 

The capsule segment in the gabapentin market is predicted to witness the largest revenue of 50 % by the end of 2036. The gabapentin medication is available in the market in various forms but the most popular and demanding form is the capsule form, owing to its easy availability, ease of administration, and correct dosing. One of the significant advantages of capsules is that they are easy to swallow which means old people or kids can take them easily and most doctors prescribe capsules over other forms owing to their huge properties. 

Our in-depth analysis of the global gabapentin market includes the following segments:

 

     Dosage Form

  • Tablet
  • Capsule
  • Oral Solution

 

     Type

  • Generic
  • Branded

 

 

     Application

  • Neuropathic Pain
  •  Epilepsy
  • Restless Legs
  • Syndrome
  • Others

 

     Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Abhishek Verma


  • Report ID: 5130
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of gabapentin is evaluated at USD 2.2 Billion.

The gabapentin market size was over USD 2.1 Billion in 2023 and is poised to cross USD 3.91 Billion by 2036, growing at more than 4.9% CAGR during the forecast period i.e., between 2024-2036. The rising prevalence of neuropathic pain and the increasing availability of generic versions are some of the major factors anticipated to drive the growth of the market.

North America industry is expected to hold 35% of the revenue share by 2036, due to growing prevalence of chronic pain conditions in the region.

Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla USA, Inc., BP Pharmaceuticals Laboratories Company, Assertio Holdings, Inc., Arbor Pharmaceuticals, Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample